Goodwill and Other Intangible Assets

9 Months Ended

Mar. 31, 2018

Goodwill and Intangible Assets Disclosure [Abstract]

The changes in the carrying amount of goodwill for the nine months ended March 31, 2018, were as follows:



Goodwill as of June 30, 2017	$	12,692
Addition related to the acquisition of Cobalt	19,791
Effect of foreign currency changes on goodwill	(5		)
Goodwill as of March 31, 2018	$	32,478

The components of other intangible assets were as follows:



	As of March 31, 2018			As of June 30, 2017			Estimated Useful Life (in years)	Weighted Average Remaining Useful Life (in years)
Definite-lived intangibles:
Reacquired franchise rights	$	1,383		$	1,383		5	1.6
Dealer relationships	86,150			29,852			8-20	19.0
Patent	3,986			1,386			12-15	14.1
Trade name	24,667			24,667			15	3.5
Non-compete agreement	54			54			10	6.6
Backlog	96			96			0.3	0.0
Total	116,336			57,438
Less: Accumulated amortization	(51,738		)	(47,841		)
Total definite-lived intangible assets, net	64,598			9,597
Indefinite-lived intangible:
Trade name	31,000			—
Total other intangible assets, net	$	95,598		$	9,597

Amortization expense recognized on all amortizable intangibles was $1,291 and $550 for the three months ended March 31, 2018 and 2017, respectively and $3,903 and $1,649 for the nine months ended March 31, 2018 and 2017, respectively.

The estimated future amortization of definite-lived intangible assets is as follows:



Fiscal years ending June 30:
	Remainder of 2018	$	1,296
	2019	5,088
	2020	4,888
	2021	4,802
	2022	3,354
	Thereafter	45,170
		$	64,598

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details